Government bans 14 FDC drugs citing safety concerns and lack of therapeutic justification.
- Government imposes ban on 14 FDC drugs citing safety concerns and lack of therapeutic justification
- Popular FDC drugs like Nimesulide and Paracetamol dispersible tablets are among those banned
- Ban aims to protect public health and safety from potential risks associated with these drugs
Caution: The Following Drug Combinations are Banned
Among the 14 banned FDC drugs are:- Nimesulide + Paracetamol dispersible tablets
- Chlorpheniramine Maleate + Codeine Syrup
- Pholcodine + Promethazine
- Amoxicillin + Bromhexine
- Bromhexine + Dextromethorphan + Ammonium Chloride + Menthol
- Paracetamol + Bromhexine + Phenylephrine + Chlorpheniramine + Guaiphenesin
- Salbutamol + Bromhexine
The Health Ministry's notification further confirms that the Central Government, based on recommendations from the Expert Committee and the Drugs Technical Advisory Board, deems it necessary and expedient to regulate and prohibit the manufacture, sale, and distribution of these drugs for human use in the country.
This recent ban is reminiscent of a previous action taken in 2016 when the government prohibited 344 drug combinations. The decision was made after an expert panel, initiated by the Supreme Court, raised concerns about these combinations being sold to patients without sufficient scientific data. The manufacturers contested the order in court, and the current list of 14 banned FDCs is part of those 344 combinations (1✔ ✔Trusted Source
Crippled Pharmacovigilance: A Qualm of Medical Profession!
Go to source).
Factors that can Influence a Drug Ban
Following factors can influence a drug ban- Adverse Effects caused by the drug
- Availability of safer alternatives
- Harmful interactions between the drug and other medications or substances
- Irrational use of drugs, including illicit drugs
- Harmful interactions with other drugs
- Failure of risk management
Reference:
- Crippled Pharmacovigilance: A Qualm of Medical Profession! - (https://www.jcdr.net/article_fulltext.asp?id=349#)
Source-Medindia